Can you provide the last earnings date for LANTERN PHARMA INC?
LANTERN PHARMA INC (LTRN) last reported earnings on 3/30/2026.
LANTERN PHARMA INC (LTRN) Earnings History & Surprises
NASDAQ:LTRN • US51654W1018
Current stock price
2.46 USD
+0.15 (+6.49%)
At close:
2.59 USD
+0.13 (+5.28%)
After Hours:
LTRN Earnings overview
Past quarterly earnings results for LANTERN PHARMA INC (LTRN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 5, 2026
Last Reported
Most Recent- Release Date
- Mar 30, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.36
- EPS Surprise
- 23.27%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 38%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.36 | -0.47 | 23.27% | 33.33% | - | - | ||
| Q3 2025 | -0.39 | -0.48 | 18.65% | 7.14% | - | - | ||
| Q2 2025 | -0.40 | -0.49 | 19.14% | 13.04% | - | - | ||
| Q1 2025 | -0.42 | -0.50 | 15.97% | 17.65% | - | - | ||
| Q4 2024 | -0.54 | -0.52 | -3.81% | -38.46% | - | - | ||
| Q3 2024 | -0.42 | -0.57 | 26.47% | -44.83% | - | - | ||
| Q2 2024 | -0.46 | -0.56 | 18.00% | -4.55% | - | - | ||
| Q1 2024 | -0.51 | -0.44 | -16.28% | -41.67% | - | - | ||
| Q4 2023 | -0.39 | -0.41 | 4.41% | -25.81% | - | - | ||
| Q3 2023 | -0.29 | -0.46 | 37.51% | -38.10% | - | - | ||
| Q2 2023 | -0.44 | -0.44 | 0.45% | -7.32% | - | - | ||
| Q1 2023 | -0.36 | -0.49 | 26.47% | 5.26% | - | - | ||
| Q4 2022 | -0.31 | -0.48 | 35.34% | 3.13% | - | - | ||
| Q3 2022 | -0.21 | -0.49 | 57.11% | 41.67% | - | - | ||
| Q2 2022 | -0.41 | -0.53 | 22.70% | -95.24% | - | - | ||
| Q1 2022 | -0.38 | -0.30 | -28.47% | -58.33% | - | - | ||
| Q4 2021 | -0.32 | -0.41 | 22.22% | 31.91% | - | - | ||
| Q3 2021 | -0.36 | -0.27 | -32.35% | -33.33% | - | - | ||
| Q2 2021 | -0.21 | -0.27 | 20.81% | - | - | - | ||
| Q1 2021 | -0.24 | -0.28 | 12.85% | - | - | - | ||
| Q4 2020 | -0.47 | -0.46 | -1.64% | - | - | - | ||
| Q3 2020 | -0.27 | -0.34 | 20.59% | - | - | - | ||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
12.49%
Max EPS beat (4)
19.14%
Min EPS beat (4)
-3.81%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, LTRN has beaten EPS estimates in 3 out of 4 releases
In the last 4 quarters, LTRN has beaten the EPS estimates by 12.5% on average.
Related analysis
LANTERN PHARMA INC / LTRN Earnings FAQ
Did LTRN stock beat earnings estimates in the most recent quarter?
LANTERN PHARMA INC (LTRN) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often LANTERN PHARMA INC beats earnings estimates?
In the last 4 quarters, LANTERN PHARMA INC (LTRN) has beaten EPS estimates in 3 out of 4 releases.